Cell line |
Primary tumor |
Origin of cells |
Estrogen receptors |
Progesterone receptors |
ERBB2 amplification |
Mutated TP53 |
Tumorigenic in mice |
|
600MPE |
Invasive ductal carcinoma |
|
+ |
– |
|
– |
|
|
AU565 |
Adenocarcinoma |
|
– |
– |
+ |
– |
|
|
BT-20 |
Invasive ductal carcinoma |
Primary |
No |
No |
No |
Yes |
Yes |
|
BT-474 |
Invasive ductal carcinoma |
Primary |
Yes |
Yes |
Yes |
Yes |
Yes |
|
BT-483 |
Invasive ductal carcinoma |
|
+ |
+ |
|
– |
|
|
BT-549 |
Invasive ductal carcinoma |
|
– |
– |
|
+ |
|
|
Evsa-T |
Invasive ductal carcinoma, mucin-producing, signet-ring type |
Metastasis (ascites) |
No |
Yes |
? |
Yes |
? |
|
Hs578T |
Carcinosarcoma |
Primary |
No |
No |
No |
Yes |
No |
|
MCF-7 |
Invasive ductal carcinoma |
Metastasis (pleural effusion) |
Yes |
Yes |
No |
No (wild-type) |
Yes (with estrogen supplementation) |
|
MDA-MB-231 |
Invasive ductal carcinoma |
Metastasis (pleural effusion) |
No |
No |
No |
Yes |
Yes |
|
SkBr3 |
Invasive ductal carcinoma |
Metastasis (pleural effusion) |
No |
No |
Yes |
Yes |
No |
|
T-47D |
Invasive ductal carcinoma |
Metastasis (pleural effusion) |
Yes |
Yes |
No |
Yes |
Yes (with estrogen supplementation) |
|
No comments:
Post a Comment